Clinical tolerance and immunologic effects after single or repeated administrations of the synthetic immunomodulator Murabutide in HIV-1-infected patients

Correction of the virus-induced deficits in innate immunity of HIV-infected subjects could well contribute to enhanced immune recovery and efficacious control of viral replication. The safe synthetic immunomodulator Murabutide (ISTAC Biotechnology, Lille, France) has been found to regulate the funct...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of acquired immune deficiency syndromes (1999) 2002-07, Vol.30 (3), p.294-305
Hauptverfasser:	AMIEL, Corinne, DE LA TRIBONNIERE, Xavier, VIDAL, Vincent, DARCISSAC, Edith, MOUTON, Yves, BAHR, George M
Format:	Artikel
Sprache:	eng
Schlagworte:	Acetylmuramyl-Alanyl-Isoglutamine - adverse effects Acetylmuramyl-Alanyl-Isoglutamine - analogs & derivatives Acquired Immunodeficiency Syndrome - drug therapy Acquired Immunodeficiency Syndrome - immunology Adjuvants, Immunologic - adverse effects Adult Biological and medical sciences CD4-CD8 Ratio Cytokines - blood Female HIV-1 Humans Immunomodulators Lymphocyte Activation Male Medical sciences Middle Aged Pharmacology. Drug treatments Receptors, CCR5 - analysis Receptors, CXCR4 - analysis Receptors, Interleukin-2 - analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!